investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Role of ASXL1 mutations in myeloid malignancies
Omar Abdel-Wahab
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Omar Abdel-Wahab
Memorial Sloan Kettering Cancer Center
New York, United States
Related projects
Joseph H Antin
A Randomized Trial of Tac/MTX/bortezomib vs Tac/MTXplacebo in Allogeneic HSCT
Leukaemia
James J-D Hsieh
Molecular Mechanisms of Impaired DAN Damage Response in Leukemia Pathogenesis
Leukaemia
Pathology
Bruno Calabretta
Targeting the C/EBPalpha-Gfi-pathway in CML stem cells
Leukaemia
Pathology
Hematology and hematologic malignancies
Kapil Bhalla
Novel Targeted Therapy for AML
Leukaemia
David FitzGerald
Bio-Therapies for the Treatment of Cancer
Leukaemia
Irving L. Weissman
HSC Diversity, in aging, ontogeny, and transformation
Leukaemia
Scott E Evans
Epithelial mechanisms of inducible resistance to AML-associated pneumonia
Leukaemia
Hongbo Chi
Tsc1/mTOR axis in immune homeostasis and tumorigenesis
Leukaemia
Dean W Felsher
Mechanisms by which Oncogene Inactivation Elicits Tumor Cell Death
Leukaemia